Karyopharm Therapeutics Inc. (KPTI) Insider Trading

Name: Karyopharm Therapeutics Inc. (KPTI) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Oct 2, 2026): Abate Kristin (Chief Accounting Officer): Sale of 378 shares, $449.82.

Get alerted when insiders trade KPTI

Email address

Loading company data...

Beta

Loading company details...

Beta